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ABSTRACT
To identify cell cycle regulators that enable cancer cells to replicate DNA and divide in an unrestricted
manner, we performed a parallel genome-wide RNAi screen in normal and cancer cell lines. In addition to
many shared regulators, we found that tumor and normal cells are differentially sensitive to loss of the
histone genes transcriptional regulator CASP8AP2. In cancer cells, loss of CASP8AP2 leads to a failure to
synthesize sufﬁcient amount of histones in the S-phase of the cell cycle, resulting in slowing of individual
replication forks. Despite this, DNA replication fails to arrest, and tumor cells progress in an elongated S-
phase that lasts several days, ﬁnally resulting in death of most of the affected cells. In contrast, depletion of
CASP8AP2 in normal cells triggers a response that arrests viable cells in S-phase. The arrest is dependent
on p53, and preceded by accumulation of markers of DNA damage, indicating that nucleosome depletion
is sensed in normal cells via a DNA-damage -like response that is defective in tumor cells.
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Introduction
The cell cycle can be divided into two distinct periods, the
interphase and the mitotic phase (M). During the interphase,
cells are growing and duplicating their DNA, whereas in the
mitotic phase, cells divide into two daughter cells. Interphase
consists of three separate phases: gap1 (G1), DNA-synthesis
(S) and gap2 (G2). Passing from one phase of cell cycle to
the next is mainly regulated by cyclins and cyclin-dependent
kinases. During the cell cycle, several checkpoints control
that cells are ready to pass from one phase to the next. Inter-
phase has two main checkpoints. One is in G1 phase, ensur-
ing that everything is ready for DNA replication and the
other is in G2 phase to verify that DNA replication is com-
pleted and that any damage to DNA is repaired. In addition,
during the S phase, when the entire genome is replicated
several checkpoint pathways can be activated as a response
to DNA damage or stalled replication forks.
DNA replication is tightly coordinated with chromatin
assembly, which depends on the recycling of parental histones
and deposition of newly synthesized histones.1 Drosophila and
yeast S. cerevisiae cells can complete S phase without de novo
histone synthesis.2,3 However, loss of histone expression or lim-
iting assembly of nucleosomes to DNA by targeting chromatin
assembly factors such as CAF-1, ASF1 and SLBP have been
reported to induce S phase arrest in human tumor cells.4-8 How-
ever, the mechanism of this arrest is still poorly understood.
Many regulators of the cell cycle have been identiﬁed by loss
of function screens in yeast. Genome-wide RNAi screens have
subsequently been used to identify both regulators that are con-
served in and speciﬁc for higher organisms such as Drosophila9
and human.10-14 In addition to differences between species, reg-
ulation of the cell cycle is often altered in normal and tumor
cells from the same organism. This is thought to be at least in
part due to mutations in cell cycle regulatory proteins such as
RB115 and p53.16 However, a systematic comparative study that
would identify regulators that are differentially required in nor-
mal and tumor cells has not been performed.
Results
Genome-wide RNAi screen identiﬁes differential regulation
of S-phase progression in normal and cancer cells
To understand similarities and differences in cell cycle regula-
tion in normal and cancer cells, we performed a genome-wide
RNAi screen simultaneously in two distinct cell lines: the osteo-
sarcoma cell line U2OS and the hTERT-immortalized normal
retinal pigment epithelial cell line hTERT-RPE1.
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U2OS and hTERT-RPE1 cells grown on 96-well plates were
transfected in triplicate with the same transfection mixes, con-
taining pooled siRNAs (Qiagen) targeting a single gene per
well. A total of 23 348 genes were targeted, and the cell cycle
phase of the cells was analyzed after 3 d using laser scanning
cytometry (Fig. 1A). For 17 095 targeted genes a total of 5 phe-
notypes were analyzed: the total number of cells, the fraction of
cells in G1, S and G2 phases, and the fraction of cells that had
higher DNA content than G2 phase cells (overG2; Fig. 1B,
Table S1). These represent cells that have replicated DNA more
than once without dividing.
In general, RNAi treatments targeting genes known to be
required for mitosis (e.g. CDK1, PLK1, KIF11) had similar
phenotypes in both cell lines (Fig. 1B, Fig. S1A). However,
many genes whose loss decreased the fraction of cells in
S-phase were different between the cell lines. Analysis of the
hits using GOstat17 revealed that ribosomal proteins were
enriched in this population in RPE1 cells (enriched GO
terms: ribosome biogenesis (GO:0042254) p-value D 1.86e-
19, rRNA processing (GO:0006364) p-value D 2.9e-16, cyto-
solic ribosome (GO:0005830) p-value D 1.51e-10), whereas
many ribosomal proteins and proteins involved in ribosome
biogenesis (e.g., WDR75) caused an increase in S-phase of
the U2OS tumor cells (Fig. S1B). This effect is likely due to
the known role of p53 in detecting translational stress,18,19
and the weak activity of p53 pathway in U2OS cells due to
MDM2 overexpression.20 Consistently, in an earlier screen,
Kittler et al. reported that in HeLa cells,14 which lack p53
function, loss of ribosomal proteins leads to increase in cells
in S-phase.
GOstat analysis of the genes whose loss leads to an increase
in S-phase also revealed that in hTERT-RPE1 cells, most of the
S-phase arrested target genes (such as PCNA, POLA1, RBX1,
RRM2) are required for DNA replication and DNA repair
(enriched GO terms: DNA metabolic process (GO:0006259)
p-value D 2.15e-06, cellular response to DNA damage stimulus
(GO:0006974) p-value D 2.99e-06, DNA repair (GO:0006281)
p-value D 5.54e-06) (Fig. 1C).
Figure 1. Genome-wide RNAi screen comparing normal and tumor cells. (A) Schematic representation of genome-scale RNAi screening in human immortalized (hTERT-
RPE1) and cancer (U2OS) cell lines. (B) Hierarchical clustering of cell cycle regulators (z-score for at least one parameter is >5 or <¡5) based on their phenotypic scores
(for full data, see Supplementary Table S1). Note that known genes required for cell division (e.g., CDK1, KIF11, PLK1) cluster together for both cell lines. (C) S-phase z-
scores in hTERT-RPE1 and U2OS cell lines. Most S-phase arrested hits for hTERT-RPE1 are genes involved in DNA replication and S-phase progression (marked black). Tran-
scriptional regulators of histone genes are marked in red.
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One of the strongest S-phase phenotypes in both cell lines was
caused by siRNAs targeting caspase 8 associated protein 2 (CAS-
P8AP2, also known as FLASH; Fig. 1C). CASP8AP2 was originally
identiﬁed as a caspase-8-associated protein,21 and is localized in
several sub-nuclear bodies (promyelocytic leukemia bodies (PML
bodies), Cajal bodies (CBs), and histone locus body (HLB)22-25)
and has been reported to participate in several cellular processes,
including processing of histone mRNAs,26 regulation of apopto-
sis,21,27 and transcriptional control.28-30 CASP8AP2 was also the
strongest S-phase regulator in a secondary screen with a Dharma-
con siRNA library targeting 55 of the identiﬁed cell cycle genes in
nine different cell lines (Table S2, Fig. S2A). siRNA targeting of
two other known regulators of histone gene transcription,
NPAT and HINFP also resulted in an increase in the fraction of
cells in the S-phase in most of the nine cell lines studied.
Loss of histone gene transcription regulators differentially
affects S-phase progression
To validate disruption of S-phase progression by loss of the regu-
lators of histone genes we transfected U2OS and hTERT-RPE1
cells with CASP8AP2, NPAT, HINFP and control siRNA pools
(Fig. S2B) and then measured the DNA synthesis rate by incor-
poration of the thymidine analog 5-Ethynyl-2-deoxyuridine
(EdU). In both U2OS and hTERT-RPE1 cells, knockdown of
CASP8AP2 dramatically decreased EdU incorporation in S-
phase. Knockdown of NPAT and HINFP had a similar effect in
U2OS cells with accumulation of cells with poor EdU incorpo-
ration. However, in hTERT-RPE1 cells depletion of NPAT and
HINFP failed to appreciably affect S-phase progression (Fig. 2A).
CASP8AP2, NPAT, HINFP and E2F1 have different impact
on histone gene expression
To determine the effect of loss of CASP8AP2, NPAT and HINFP
on histone gene expression, we proﬁled gene-expression in siRNA
treated U2OS and hTERT-RPE1 cells using Affymetrix WT1.1
arrays (Table S3). We found that CASP8AP2, NPAT and HINFP
do not regulate expression of each other, but mainly affect the
expression of histone genes. Most histone genes were downregu-
lated in U2OS cells following loss of CASP8AP2, NPAT or HINFP
(Fig. 2B, Table S3). In normal cells, some highly expressed histone
genes were downregulated (e.g., histone H3), albeit less than in
tumor cells (Fig. S3). In addition, many histone genes that are nor-
mally expressed at lower levels were upregulated (Fig. S3).
To identify whether CASP8AP2, NPAT and HINFP directly
bind to the histone gene promoter regions we performed ChIP-
Seq in U2OS and hTERT-RPE1 cells. Consistent with previous
ﬁndings, HINFP was found enriched near transcription start
sites (TSSs) of replication-dependent histones H4 and H2B31-34
(Tables S4 and S5). We also found that HINFP regulated
two replication-independent histone H1 genes, H1F0 and
H1FX (Tables S4 and S5). In contrast, CASP8AP2 and NPAT
ChIP-Seq peaks were only found colocalized at replication-
dependent histone genes on chromosomes 1, 6 and 12 in both
cell lines (Fig. 2C, Tables S4 and S5). These results indicate
that CASP8AP2 and NPAT regulate only replication-dependent
histones, whereas HINFP regulates a subset of replication
dependent histones (H4 and H2B), and two replication-inde-
pendent H1 variants (H1F0 and H1FX).
Another histone gene regulator, E2F1,35,36 also bound to
TSSs of many histone genes, including both replication depen-
dent and independent histones (Tables S4 and S5). In addition,
E2F1 bound to the promoter of CASP8AP2, suggesting that
E2F proteins control CASP8AP2 and histone expression
directly and via a feed-forward loop, respectively.
CASP8AP2 knockdown results in low histone H3 protein
levels and slows progression of replication forks in U2OS
osteosarcoma cells
To analyze the long-term effect of CASP8AP2 loss on S-phase
progression and histone protein levels, we treated U2OS and
hTERT-RPE1 cells with CASP8AP2 siRNAs, and analyzed DNA
content, histone H3 protein level, and EdU incorporation by ﬂow
cytometry in the same population of the cells. We found that CAS-
P8AP2 siRNA treatment did not completely arrest U2OS cells in
S-phase, but instead dramatically slowed down S-phase progres-
sion. The slow rate of EdU incorporation of S-phase cells at all
time points analyzed, together with the moving of the S phase
population to progressively higher DNA content over time indi-
cates that the cells are progressing in S-phase at a very slow rate,
with a single S-phase lasting more than 3 d on average (Fig. 3A).
The slowdown in S-phase was accompanied by increased cell
death in U2OS, based on decrease in cell number over time, and
increase in sub-G1 population in ﬂow cytometry (Fig. S4B). In
addition, we detected a marked decrease in histone H3 protein
levels in the surviving cells that continued to replicate (Fig. 3B).
In contrast, viable hTERT-RPE1 cells were arrested in early S-
phase by CASP8AP2 siRNA, and displayed also a decrease in his-
tone H3 protein at this cell cycle stage. However, H3 protein levels
appeared normal in cells that had progressed further in S-phase
and in G2 cells (Fig. 3C–D). Analysis of total H3 protein level by
western blot indicated that H3 levels were decreased in U2OS, but
not in RPE1 cells (Fig. S4C). Control experiments established that
as previously reported,37 the vast majority of histone H3 protein
in both cell lines is assembled to chromatin, indicating that very
little free H3 exists in either cell type (Fig. S4D). This result indi-
cates that U2OS cells can replicate their DNA in the absence of
normal nucleosome levels, leading to accumulation of cells with
low levels of H3. However, normal cells sense the depletion of the
nucleosome pool and only complete DNA replication in the pres-
ence of sufﬁcient amount of nucleosomes.
To identify the mechanism of the slowdown of the cell cycle
in the U2OS cells, we analyzed the speed of replication forks in
CASP8AP2 siRNA treated U2OS cells using a DNA ﬁber assay,
where DNA is labeled by two different labels consecutively, and
then analyzed visually to detect the length of the labeled
regions. This analysis conﬁrmed earlier observations38 that
CASP8AP2 siRNA generally decreases the speed by which rep-
lication forks progress (Fig. S5A-C), suggesting that in human
cancer cells, individual replication forks are affected by nucleo-
somes loading behind them.
The ability of normal cells to activate H2AX
phosphorylation in response to deregulation of histone
expression is p53 dependent
To determine why normal and tumor cells respond differ-
entially to CASP8AP2 loss, we examined the expression
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proﬁles of non-histone genes after CASP8AP2, NPAT and
HINFP siRNA treatment. This analysis revealed that p53
target genes were upregulated in hTERT-RPE1, but not in
p53-proﬁcient U2OS cells (Fig. 4A). The p53 target genes
were upregulated relatively late, clearly after the changes in
histone gene expression were observed (Fig. S6A-B,
Table S6).
One possibility that would explain the activation of p53 is
that the slow replication causes DNA damage or a DNA
damage-like state that is sensed by p53. Consistently with
Figure 2. Regulation of DNA synthesis and expression of histone genes by CASP8AP2, NPAT and HINFP. (A) Flow cytometric analysis of DNA content (x-axis) and DNA rep-
lication (EdU incorporation; y-axis) shows partial or complete DNA synthesis progression 3 d after knockdown of CASP8AP2, NPAT and HINFP in tumor (U2OS) and normal
(hTERT-RPE1) cells. Note that in both cell lines, CASP8AP2 RNAi results in formation of a population of S-phase cells with low EdU incorporation (red arrowheads). (B) Anal-
ysis of expression of histone genes following knockdown of the indicated genes in U2OS and hTERT-RPE1 cells. Replication-independent histone genes are marked with
an asterisk. (C) Location-analysis of transcriptional regulators at histone gene cluster on chromosome 6p22. Cell lines and antibodies used in ChIP-Seq are indicated on
the left, and signal intensity as number of reads is shown in parentheses above each track. Note that CASP8AP2 and NPAT co-bind to transcription start sites of replica-
tion-dependent histone genes (indicated in bottom) in this cluster.
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this hypothesis, an increase in a marker commonly associ-
ated with DNA damage, gamma-H2AX, was observed more
in hTERT-RPE1 cell line (Fig. 4B, Fig. S6C-D) and less in U2OS
cell line (Fig. 4C, Fig. S6C-D). We analyzed also other markers,
which revealed modest increase in single-stranded DNA (RPA)
and DNA damage repair (53BP1) markers, indicating that there is
some DNA damage-like pathway activation also in U2OS cells,
but that this level of activation is not sufﬁcient to completely arrest
the cells in the S phase (Fig. S7A-D). To address whether the p53-
dependent pathway is responsible for the S-phase arrest observed
in normal but not in tumor cells, we analyzed the expression of
the p53 target gene p21. We found that after CASP8AP2 RNAi
treatment, p21 protein was induced more in hTERT-RPE1 cells
(Fig. S8A), and only in S-phase cells that express elevated gamma-
Figure 3. Tumor cells continue to progress in S-phase despite low nucleosome levels induced by CASP8AP2 knockdown. (A, B) Flow cytometry analysis of DNA content,
DNA replication and histone H3 levels in siRNA treated cells. Note that tumor cells continue to replicate their DNA slowly (A) for multiple days, despite low amount of his-
tone H3 (red arrowheads) (B). (C, D) Flow cytometry analysis of DNA content, DNA replication (EdU staining) and histone H3 levels in siRNA treated hTERT-RPE1 cells.
Note that normal cells arrest in S-phase (C), and show decrease in histone H3 levels in early S-phase (red arrowheads) (D).
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H2AX (Fig. 4D–E). Similar results were found in two other nor-
mal human cell lines, HFL1 and CCD-1112Sk (Fig. S9A-D).
To test if the effect is dependent on p53, we generated a
derivative of hTERT-RPE1 cell line that lacks p53 using
CRISPR/Cas9 genome engineering. This cell line failed to
completely arrest in S-phase or induce p21 in response to CAS-
P8AP2 RNAi (Fig. S8A-B). In addition, signiﬁcantly lower lev-
els of gamma-H2AX accumulation were observed in the p53
deﬁcient cell line (Figs. S6C-D and S9A-D). The response of
the p53 deﬁcient cell line was similar to that of tumor cells,
including U2OS and HCT116 (Fig. S9A-D, Table S7).
Discussion
Genome-wide RNAi screens have become very powerful and
informative approaches for the analysis of cell cycle regulation
and for identiﬁcation of new regulators of cell cycle progression
and checkpoint control. Unlike previously published genome-
wide RNAi screens performed to identify genes affecting cell
cycle and cell size in Drosophila cells9 and in human cancer
cells10-14 the present study compares two distinct cell lines: the
osteosarcoma cell line U2OS and the hTERT-immortalized
normal retinal pigment epithelial cell line hTERT-RPE1. As
expected, several known mitotic regulators, and the known
transcriptional regulator of histones, CASP8AP2 displayed
strong phenotypes in both types of cells. However, some DNA-
replication regulators, including two other transcriptional regu-
lators of histones, HINFP and NPAT, displayed differential
effects in the two cell types.
The canonical histones are exclusively expressed in S phase of
cell cycle.36,39,40 This process is regulated by E2F and cyclin E-
Cdk2 kinase through phosphorylation of NPAT.33,35,41-43 Based
on microarray data and ﬂow cytometry, the depletion of CAS-
P8AP2 caused strong downregulation of replication-dependent
histones in U2OS cells. In normal cells, loss of CASP8AP2 also
resulted in deregulation of histone expression, resulting in both
positive and negative effects at the level of individual histone genes.
The transcriptional regulation of histone genes by CASP8AP2 and
NPAT is likely direct, based on their known interaction,44 and our
chromatin immunoprecipitation followed by sequencing (ChIP-
seq) results showing localization of NPAT and CASP8AP2 almost
exclusively to the replication-dependent histone loci.
In order to understand the mechanism behind the differen-
tial response of normal and tumor cells, we analyzed the S-
phase phenotypes in more detail, using EdU incorporation
assays in multiple tumor and normal cells depleted of CAS-
P8AP2. This analysis revealed that the increase in cells in the S-
phase observed in tumor cells after CASP8AP2 loss was not
caused by an S-phase arrest. Instead, it resulted from a dramatic
slowdown of DNA replication. In contrast, the S-phase pro-
gression of normal cells was arrested. Further analysis revealed
also that the deregulation of nucleosome gene expression trig-
gers a p53-dependent pathway in normal cells, but not in
U2OS tumor cells. Thus, p53 activation is a consequence, not
the cause, of the observed DNA replication phenotype.
One possibility that would explain the activation of p53 is
that imbalance of histone proteins and the disruption of repli-
cation process causes DNA damage or a DNA damage-like
state that is sensed by p53. Consistently with this hypothesis,
an increase in a marker commonly associated with DNA dam-
age, gamma-H2AX, was observed in hTERT-RPE1 cells follow-
ing CASP8AP2 knockdown. Much lower levels of the marker
Figure 4. CASP8AP2 siRNA triggers activation of a p53 dependent S-phase checkpoint in normal but not in tumor cells. (A) Analysis of p53 target gene expression 3 d
after knockdown of the indicated transcriptional regulators of histone genes. (B, C) Flow cytometry analysis of CASP8AP2 siRNA treated hTERT-RPE1 (B) and U2OS (C) cells
indicates that non-replicated cells arrested in S-phase express a marker for DNA damage signaling (g-H2AX; low right hand corner). (D, E) hTERT-RPE1 (D) but not U2OS
(E) cells with activated DNA damage signaling have activated p53, based on expression of the p53 target-gene p21 (upper right hand corner).
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were seen in similarly treated U2OS cells. Thus, downregula-
tion of histones in tested cancer cells could cause slow progres-
sion through S-phase without sufﬁcient accumulation of DNA
damage marker to activate p53-dependent cell cycle arrest. It is
consistent with previous result where short-term depletion of
histone genes by CASP8AP2 knockdown did not induce DNA
damage markers.38
In summary, we have through a genome-wide analysis of
normal and tumor cells identiﬁed a signiﬁcant difference in reg-
ulation of cell cycle arrest in response to abnormal regulation of
histone genes transcription. In both normal and tumor cells, the
depletion of CASP8AP2 alters mainly the expression of replica-
tion-dependent histones. Whereas hTERT-RPE1 cells respond
by triggering a p53-dependent checkpoint, which leads to cell
cycle arrest and recovery, U2OS cells continue to progress in S-
phase, leading to cell death. The difference between normal and
tumor cells was observed in all tested cell types, including eight
tumor cell lines and three different normal cell types. Further
investigation is necessary to assess the generality of this differ-
ence, and to determine whether the cell death in the cell lines
studied here is caused by accumulation of DNA damage, or
mediated more directly by CASP8AP2, which has been reported
to have an anti-apoptotic role.27 The identiﬁed defect in sensing
histone expression levels could also in part explain the abnormal
nuclear morphology commonly associated with cancer cells.
Furthermore, the identiﬁed novel vulnerability of cancer cells
can potentially be used for therapeutic purposes in the future.
Methods
Cell culture
U2OS human osteosarcoma (from M. Laiho lab, University Hel-
sinki), HeLa human cervix adenocarcinoma (from M. Laiho lab,
University Helsinki), HT1080 human ﬁbrosarcoma (from ATCC,
CRL-121), PC3 prostate adenocarcinoma (from Gonghong Wei,
University Oulu), SK-N-MC human brain neuroepithelioma
(from Gonghong Wei, University Oulu), SW480 colorectal ade-
nocarcinoma (from Gonghong Wei, University Oulu) cells were
cultured in DMEM supplemented with 10% fetal bovine serum
and antibiotics (100 units/ml penicillin and 100 mg/ml strepto-
mycin). The hTERT-immortalized retinal pigment epithelial
hTERT-RPE1 (from ATCC, CRL-4000) and hTERT-RPE1
p53KO cells lines were cultured in F12:DMEM(1:1) supple-
mented with 10% fetal bovine serum and antibiotics (100 units/
ml penicillin, 100 mg/ml streptomycin and 10 mg/ml hygromycin
B). SAOS-2 human osteosarcoma (from M. Laiho lab, University
Helsinki) were cultured in McCoy’s 5A medium supplemented
with 10% fetal bovine serum and antibiotics (100 units/ml peni-
cillin and 100 mg/ml streptomycin). SJCRH30 human rhabdo-
myosarcoma cells (from ATCC, CRL-2061) were cultured in
RPMI-1640 supplemented with 10% fetal bovine serum and anti-
biotics (100 units/ml penicillin and 100 mg/ml streptomycin).
Chromatin immunoprecipitation followed by sequencing
(ChIP-seq)
ChIP assays were performed as previously described. 45 Immu-
noprecipitations were performed with 5 mg antibody against
CASP8AP2 (sc-9088, Santa Cruz Biotechnology), NPAT (sc-
67007, Santa Cruz Biotechnology), HINFP (sc-49818, Santa
Cruz Biotechnology), E2F1 (sc-193, Santa Cruz Biotechnology),
normal rabbit IgG (sc-2027, Santa Cruz Biotechnology) and
normal goat IgG (sc-2028, Santa Cruz Biotechnology).
ChIP libraries were prepared for Illumina Genome Analyzer
or HiSeq2000 sequencing as described before.45 Sequencing
reads were mapped to the human genome (NCBI36) and peaks
called as described.46 Lists of all signiﬁcant peaks (p > 0.00001,
fold change > 2) are in Supplementary Table S4.
Laser scanning cytometry: Genome-wide RNAi screen
A Qiagen Human Whole Genome siRNA Set V4.0 was used for
transfection in U2OS and hTERT-RPE1 cell lines. Qiagen
siRNA library contains 4 pooled siRNAs in total amount of
0.5 nmol siRNA per well targeting 23348 different genes
(EntrezGene ID). The complete set contains a total of 308 £
96-well plates with each plate containing 80 wells with siRNA
constructs as well as following controls: Qiagen negative con-
trol siRNA, siRNA against GFP (Qiagen), 3 wells with transfec-
tion reagent and 3 wells with siRNA against CDK1 (custom
made positive control purchased from MWG).
For reverse transfection 4000 cells were plated in the growth
medium into 96-well plates having 15 nM siRNA and 0.7 ml
HiPerFect (Qiagen) in total volume of 125 ml. Transfection was
performed in triplicates simultaneously for U2OS and hTERT-
RPE1 cells in 16 batches. After 70–72 hours of incubation cells
were washed with PBS, ﬁxed with 70% ice cold ethanol o/n and
stained with PBS containing 30 mg/ml PI (Sigma-Aldrich) and
30 mg/ml RNase A (MACHEREY-NAGEL). The stained cells
were scanned with an Acumen eX3 microplate cytometer (TTP
LabTech).
The number of the cells in each sub-population of the cell
cycle was calculated with Acumen eX3 software. Single cell
population was speciﬁed based on area, depth and width
parameters of the signal for each object. The DNA content his-
tograms were gated manually for each batch to specify sub-G1-,
G0/G1-, S-, G2/M- and over- G2-phase populations. Total cell
number and percentages of the cells in each population were
normalized two times: ﬁrst using median of a plate and then
median of the well position in all plates (positive controls
were excluded from the normalization); then Z-score were cal-
culated for each parameter from the median of triplicates and
median of all negative controls (i.e. negative control siRNA
and GFP siRNA): Z D (x¡m)/ s, where x is the median of
triplicates for each parameter; m is the median of all negative
controls; s is the standard deviation of all negative controls.
For the ﬁnal data analysis, the siRNA sequences were
mapped to human transcripts (Ensembl version 52, genome
assembly NCBI36) using bowtie version 0.11.3. In total 79534
(81.36%) siRNAs were mapped to at least one transcript with-
out mismatches and 17095 (73%) wells have 4 siRNAs mapping
the same single target gene. After normalization only data from
the 17095 samples were used for further analysis. To identify
hits C/¡ 5 z-score cutoff was applied for all calculated parame-
ters (sub-G1, G0/G1, S, G2/M and over-G2), later on subG1
was excluded from the analysis as non-informative.
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Data analysis and visualization was performed in R using
hopach (R package version 2.20.0; http://www.stat.berkeley.
edu/»laan/, http://docpollard.org/),47 gplots packages and
GOstat(http://gostat.wehi.edu.au/).17
Secondary screen
A Dharmacon siGENOME SMARTpool of 91 siRNAs (includ-
ing negative controls) was used for transfection in 9 different
cells lines (hTERT-RPE1, U2OS, SAOS-2, SJCRH30, HeLA,
PC3, SK-N-MC, SW480 and HT1080). Transfection, screening
and data analysis was performed in the same way as with the
Qiagen library screen.
Microarray data
Sets of 4 FlexiTube GeneSolution siRNAs (Qiagen) targeting
CASP8AP2, NPAT, HINFP or AllStars Negative Control (Qia-
gen) were used. For reverse transfection protocol, cells at 30%
conﬂuence were plated in the growth medium into 6-well plates
using 15 nM siRNA and 7 ml HiPerFect (Qiagen) in ﬁnal total
volume 2.1 ml. Transfection was performed in duplicates
simultaneously for each siRNA for U2OS and hTERT-RPE1
cell lines. After 70–72 hours growing cells were collected and
RNA extraction was performed with RNeasy kit (Qiagen)
including DNase treatment according to manufacturer’s proto-
col. RNA was analyzed using Affymetrix Human WT 1.1 arrays
in the core facility for Bioinformatics and Expression Analysis
(Karolinska Institute, Stockholm, Sweden). Raw CEL data were
analyzed using the Bioconductor R packages affy48 and limma49
and for the annotation custom CDF ﬁles (ENSG)50 was used.
p53 pathway data was retrieved from KEGG (http://www.
genome.jp/kegg/).
Flow cytometry
Sets of 4 FlexiTube GeneSolution siRNAs (Qiagen) against
CASP8AP2, NPAT, HINFP or AllStars Negative Control (Qia-
gen) were used for reverse transfection protocol as in microar-
ray analysis. Although the replicates performed in the same day
are highly consistent, and qualitatively similar phenotypes were
reproducibly observed in experiments performed in different
days, some variance to the penetrance of the phenotypes was
observed between experiments performed in different days
(e.g., Supplementary Fig S8 and Fig. 4). This effect does not
materially affect the conclusions drawn, and is most likely
attributable to differences in transfection efﬁciency.
Cells were incubated with 10 mM EdU (Life Technologies)
for last 1 hour before harvesting and ﬁxing with 70% ice cold
ethanol on 1, 2 and 3 d after transfection. The cells were washed
with 1% BSA in PBS and prepared for ﬂow cytometry with
Click-iT EdU Alexa Fluor 647 Flow Cytometry Assay Kit
(Life Technologies) according to the manufacturer’s protocol.
For the ﬂow cytometry analysis of total histone H3 cells
were harvested and ﬁxed with 70% ice cold ethanol on 1, 2
and 3 d after transfection and left overnight in ¡20C. On
the next day the cells were washed with 1% BSA in PBS
several times and blocked in 1% BSA in PBS for at least an
hour followed by overnight incubation at C4C with
histone H3 antibody (1:500, #9715, Cell Signaling Technol-
ogy, or 1:500, ab1791, Abcam), g-H2AX(1:500, #9718, Cell
Signaling Technology), p21 (1:100, sc-6246, Santa Cruz Bio-
technology) or as a control normal rabbit IgG (1:200, sc-
3888, Santa Cruz Biotechnology), normal mouse IgG (1:200,
sc-2025, Santa Cruz Biotechnology). The cells were washed
several times with 1% BSA in PBS and incubated with sec-
ondary antibodies (anti-rabbit Alexa488 or anti-mouse
Alexa488, Life Technologies) for an hour. After several
washes with 1% BSA in PBS cells were stained for DNA
content with 5mM DRAQ5 (BioStatus Limited) and 10 mg/
ml RNaseA (MACHEREY-NAGEL) for 30 min. Flow
cytometry was performed using MACSQuant Analyzer (Mil-
tenyi Biotec) and data analyzed using FlowJo (FlowJo, LLC).
Western blotting analysis
Different subcellular protein fractions from hTERT-RPE1 and
U2OS cells were extracted using Subcellular Protein Fraction-
ation Kit for Cultured Cells (78840, Pierce Biotechnology)
according to the manufacturer’s protocol. Samples were pre-
pared in Laemmli sample buffer and analyzed with 10%-SDS
PAGE followed by immunoblotting analysis using the following
antibodies: histone H3 (#9715, Cell Signaling Technology) and
a-tubulin (T9026, Sigma-Aldrich).
For the total histone H3 level analysis sets of 4 FlexiTube
GeneSolution siRNAs (Qiagen) against CASP8AP2 or AllStars
Negative Control (Qiagen) were used for reverse transfection
protocol in 6-well plates as described in microarray analysis.
10 mg of total protein was analyzed by 10% SDS-PAGE fol-
lowed by immunoblotting analysis using the following antibod-
ies: histone H3 (#9715, Cell Signaling Technology) and
a-tubulin (T9026, Sigma-Aldrich).
Detection of the antibodies was performed with Pierce ECL
plus western blotting substrate (#32132, ThermoScientiﬁc) and
processed with Gel DocTM XRC and ChemiDocTM XRSC Sys-
tems with Image LabTM 5.0 Software (Bio-Rad).
Genome editing
Generating hTERT-RPE1 p53KO cell line using CRISPR (clus-
tered regularly interspaced short palindromic repeats) in com-
plex with Cas9 (CRISPR associated protein 9) protein
technology was performed according previously published
protocol.51
The following two 23 bp guide RNAs (gRNAs) in the p53
coding region were designed using the CRISPR web tool
(http://crispr.mit.edu/):
TP53_1 in exon 4: GCATTGTTCAATATCGTCCGGGG
TP53_2 in exon 2: GCGACGCTAGGATCTGACTGCGG
Selected target sequences were incorporated into two 60-mer
oligonucleotides corresponding the exon 4 and exon two
targets.
TP53_1F for exon 4:
TTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACA
CCGCATTGTTCAATATCGTCCG
TP53_1R for exon 4:
GACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTA
AAACCGGACGATATTGAACAATGC
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TP53_2F for exon 2:
TTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAAC
ACCGCGACGCTAGGATCTGACTG
TP53_2R for exon 2:
GACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAA
AACCAGTCAGATCCTAGCGTCGC
The two oligos were annealed and extended for 30 min at
72C to make a 100 bp double stranded DNA fragment using
Phusion polymerase (NEB). Using Gibson assembly (NEB)
reaction according to the manufacturer’s protocol the 100 bp
DNA fragments were incorporated into the gRNA cloning vec-
tor (http://www.addgene.org/41824/) and the reaction products
were transformed into chemically competent DH5a cells. Plas-
mid DNA from 5 single colonies for both constructs (TP53_1
and TP53_2) were extracted using Plasmid midiprep (Qiagen).
After sequence veriﬁcation plasmids containing insertions
with TP53_1 and TP53_2 gDNAs were co-transfected with
hCas9 plasmid (http://www.addgene.org/41815/) into the
hTERT-RPE1 cells using FuGENE HD Transfection Reagent
(Promega) according to the manufacturer’s protocol.
To conﬁrm genome editing 2 d after transfection cells were
split and genotyped using Phusion polymerase (NEB) with fol-
lowing primers:
gDNA_p53_F: ACACTGACAGGAAGCCAAAGGG
gDNA_p53_R: ATCCCCACTTTTCCTCTTGCAGC
The cells with p53 KO phenotype were split in low density
into several 96 well plates to obtain single-cell colonies. After
several single-cell colonies had reached conﬂuence they were
split and p53 levels were veriﬁed with Western Blotting using
p53 antibody (1:200, DO-1, sc-126, Santa Cruz Biotechnology)
as described above. In three hTERT-RPE1 clones p53 protein
was not detected and p53 status was veriﬁed with Sanger
sequencing of genomic and cDNA with gDNA_p53 primers
and cDNA primers:
cDNA_p53_F: CAGCCAGACTGCCTTCCG
cDNA_p53_R: GACAGGCACAAACACGCACC
Of the obtained clones, we chose to use a clone with a homo-
zygous 1 bp insertion in exon 4 of p53, causing a frameshift
mutation at codon position 48, resulting in mutation of Asp 48
to Glu, and truncation of the protein after two amino-acid out-
of-frame peptide (Glu-Arg-Tyr-Stop).
DNA ﬁber assay
2 £ 105 U2OS cells were reverse transfected with either 15 nM
control or CASP8AP2 siRNA according to the manufacturer’s
protocol (HiPerFect, Qiagen). After 48 h, cells were pulse
labeled with 25 mM CldU followed by 250 mM IdU for 20 min
each and harvested immediately. DNA ﬁber spreads were pre-
pared as previously described.29 In short, DNA was denatured
using 2.5M HCl and incubated with rat anti-BrdU monoclonal
antibody (AbD Serotec, 1:1000) and mouse monoclonal anti-
BrdU antibody (Becton Dickinson, 1:750) overnight at 4C.
Objective slides were ﬁxed in 4% formaldehyde and subse-
quently incubated with an AlexaFluor 555-conjugated goat
anti-rat IgG and AlexaFluor 488-conjugated goat anti-mouse
IgG (Molecular Probes, 1:500) for 1.5 h at room temperature.
Stained DNA ﬁbers were imaged with a Zeiss LSM710 confocal
laser scanning microscope, equipped with a Plan-Apochromat
63x/1.40 Oil DIC M27 objective. Alexa 488 and 555 were
excited with a 488 nm Ar laser line and a 561 nm DPSS laser
line, respectively. Confocal images were recorded with a frame
size of 1024 £ 1024 pixels and a pixel size of 130 nm. CldU
and IdU track length were measured using ImageJ (http://rsb.
info.nih.gov/ij/) and mm values were converted into kb using
the conversion factor 1mm D 2.59 kb.52
Primary array and sequencing data are deposited in the
Gene Expression Omnibus (GEO) under accession number
GSE69149.
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